ADAMTS13 or Caplacizumab Reduces the Accumulation of Neutrophil Extracellular Traps and Thrombus in Whole Blood of COVID-19 Patients under Flow is a research paper published in Thrombosis and Haemostasis (2024). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: HL144552
National Heart, Lung, and Blood Institute
Grant: HL157975-01A1
National Heart, Lung, and Blood Institute
Grant: HL164016-01A1
NHLBI NIH HHS
Grant: R01 HL144552
NHLBI NIH HHS
Grant: R01 HL157975
NHLBI NIH HHS
Grant: R01 HL164016
NHLBI NIH HHS
Grant: HL144552, HL157975-01A1, and HL164016-01A1
FWCI
2.32
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords